News & Announcements

This page offers news-worthy topics, helpful regulatory tips, and updates to IRB/ORI policy, procedures, and guidelines for IRB Members and others involved in human research. Note: Due to the nature of web page evolution, some links may be broken.

August 17, 2020

Announcement regarding use of the Morisky Medication Adherence Scale [HTML]

WARNING:  CONSIDER ALTERNATIVES TO THE MORISKY MEDICATION ADHERENCE SCALE (MMAS-4, MMAS-8 or “Morisky Widget”)

Individuals representing the purported owner(s) of the Morisky Medication Adherence Scale (sometimes known as the MMAS-4, MMAS-8, or the Morisky/MMAS Widget – the “Tools”), and one of its authors, Dr. Donald Morisky, have sought high value fees, threatened institutions and researchers with copyright infringement and breach of contract lawsuits, and pushed for retraction of publications, when a researcher has used the Tools.

The University of Kentucky Office of Legal Counsel’s (OLC) current advice is not to use the Tools.  Further, the University will not sign any license, permission, or other document that MMAS Research, LLC, Morisky Medication Adherence Research, LLC, Dr. Morisky, or his former associate Mr. Steven Trubow, or others associated with those entities or persons, share or offer in connection with the Tools. 

If you receive an inquiry or communication from anyone associated with the Tools, please contact the OLC at (859) 257-2936 and request to speak to research or intellectual property counsel.

You are encouraged to consider using (or, if protected by copyright, requesting permission to use) an alternative to the Tools as part of any research involving medication adherence. Please be sure to obtain written permission or a signed license from an authorized licensor before using any copyrighted measurement tool. You may want to consider using, or requesting permission to use, one or more of these alternatives instead of the Tools.

David L. Kinsella
Senior Associate General Counsel


August 12, 2020

The IRB Review Newsletter [HTML]

In this issue:

  • Expedited IRB Review for Individual Patient Compassionate Use
  • COVID-19 Human Research Protocols
  • Upcoming ORI Office Hours

Please note: Individuals conducting human subjects research must review and comply with the requirements of the VPR’s Resumption of Research Phased Plan before initiating or resuming any in-person research.


June 12, 2020

The IRB Review Newsletter [HTML]

In this issue: 

  • Applying the UK Resumption of Research Plan to Human Subject Research
  • Consolidated Guide for Submitting and Conducting COVID-19 Human Research
  • Revised "UK ORI Best Practice for Remote Informed Consent Guide"
  • IRB Member Spotlight: IRB Members Dr. Hay Avasarala and Dr. Avinash Bhakta featured in recent UKNOW articles
  • Upcoming ORI Office Hours

May 1, 2020

The IRB Review Newsletter [HTML]

In this issue:

  • COVID-19 Research Announcement
  • COVID-19 Informed Consent Options
  • NEW Online Training Opportunities!
  • Other Online Training Opportunities
  • Upcoming ORI Office Hours

January 22, 2020

The IRB Review Newsletter [HTML]

In this issue:

  • Revised Common Rule: Efficiencies Experienced
  • Road to Re-accreditation
  • Upcoming ORI Office Hours

January 20, 2020

Important Information

As of January 20, 2020, According to the Revised Common Rule’s Cooperative Research Provision (45 CFR 46.114), all institutions located in the United States that are engaged in cooperative research conducted or supported by a Common Rule department or agency must rely upon approval by a Single IRB for the portion of the research conducted in the United States. For further information, click here.